Apex Bioventures to seek shareholder approval to liquidate

Apex Bioventures Acquisition Corporation (PEX on the American Stock Exchange) announced today that its board of directors determined that the company will not consummate a business combination in the time frame required, and that it is advisable that Apex be dissolved. Apex will issue a press release announcing the date of the shareholders meeting at which the Board of Directors will seek shareholder approval for a liquidation plan.